Biochemical and Morphologic Alterations in Cardiac Myocytes in Streptozotocin-Induced Diabetic Rats

  • T. Katagiri
  • Y. Umezawa
  • Y. Suwa
  • E. Geshi
  • T. Yanagishita
  • M. Yaida
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 130)

Abstract

Complication of congestive heart failure in patients with diabetes mellitus has well been known in clinical practice. Impairment of cardiac function was recognized in the absence of arteriosclerotic changes in diabetics, and the concept of “diabetic cardiomyopathy” has been proposed as the diabetes specific myocardial disorder (1,2). In the clinical practice, diabetes mellitus occurs in the mature to elder age and complication of coronary arterio- or athero-sclerosis is usual. Therefore, influence of ischemia could not be excluded in clinical cases. To elucidate effect of hyperglycemic state on cardiac myocytes without vascular changes, experimental diabetes was induced in relatively young rats by single intravenous injection of streptozotocin (STZ), and the effects of abrupt and long-standing severe hyperglycemia on the cardiac micro organs such as the sarcoplasmic reticulum (SR) and the structural proteins were investigated in comparison with the fine structures of cardiac myocytes.

Keywords

Sucrose Depression Ischemia Electrophoresis Polyacrylamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rubier S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595–602.Google Scholar
  2. 2.
    Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham Study. Am J Cardiol 1974; 34: 29–34.PubMedCrossRefGoogle Scholar
  3. 3.
    Yaida M, Umezawa Y, Konno N, Katagiri T. Alterations in cardiac sarcoplasmic reticulum and structural proteins in streptozotocin induced diabetic rats. J Showa Med Assoc 1988; 48: 175–183.Google Scholar
  4. 4.
    Yanagishita T, Konno N, Geshi E, Katagiri T. Alterations in phopholipids in acute ischemic myocardium. Jpn Circ J 1987; 51: 41–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Katagiri T. Changes of cardiac structural proteins in myocardial infarction. Jpn Heart J 1977: 18: 711–721.PubMedCrossRefGoogle Scholar
  6. 6.
    Ozawa K, Takeyama Y, Katagiri T. Electron microscopic studies on the ATPase activity in myocardial infarction. Jpn Circ J 1982; 46: 725–733.PubMedCrossRefGoogle Scholar
  7. 7.
    Konno N, Yanagishita T, Geshi E, Katagiri T. Degradation of the cardiac sarcoplasmic reticulum in acute myocardial ischemia. Jpn Circ J 1987; 51: 411–420.PubMedCrossRefGoogle Scholar
  8. 8.
    Hamby RI, Zonerai S, Sherman L. Diabetic cardiomyopathy. JAMA 1974; 229: 1749–1754.PubMedCrossRefGoogle Scholar
  9. 9.
    Regan TJ, Ettinger PO, Khan MI, Jesrani MU, Lyons MM, Oldewurtel HA, Weber M. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 1974; 35: 222–237.CrossRefGoogle Scholar
  10. 10.
    Ahmed SS, Jaferi GA, Narang RM, Regan TJ. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J 1975; 89: 153–158.PubMedCrossRefGoogle Scholar
  11. 11.
    Ledet T. Diabetic cardiopathy. Acta Path Microbiol Scand A 1976; 84: 421–428.Google Scholar
  12. 12.
    Seneviratne BIB. Diabetic cardiomyopathy: The preclinical phase. Brit Med J 1977; 1: 1444–1446.PubMedCrossRefGoogle Scholar
  13. 13.
    Fein FS, Kornstein LB, Strobeck JE, Capasso JM, Sonnenblick EH. Altered myocardial mechanics in diabetic rats. Circ Res 1980; 47: 922–933.PubMedCrossRefGoogle Scholar
  14. 14.
    Penpargkul S, Fein F, Sonnenblick EH, Scheuer J. Depressed cardiac sarcoplasmic reticular function from diabetic rats. J Mol Cell Cardiol 1981; 13: 303–309.PubMedCrossRefGoogle Scholar
  15. 15.
    Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983; 244: E528–E535.PubMedGoogle Scholar
  16. 16.
    Pierce GN, Dhalla NS. Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol 1983; 245: C241–C247.PubMedGoogle Scholar
  17. 17.
    Holman RT, Johnson SB, Gerrard JM, Mauer SM, Kupcho-Sandberg S, Brown DM. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Nat Acad Sci USA 1983; 80: 2375–2379.PubMedCrossRefGoogle Scholar
  18. 18.
    Huang YS, Horrobin DF, Manku MS, Mitchell J, Ryan MA. Tissue phopholipid fatty acid composition in the diabetic rat. Lipids 1984; 19: 367–370.PubMedCrossRefGoogle Scholar
  19. 19.
    Tarach JS. Electron microscopic cytochemical studies on lysosomes and peroxisomes of a rat cardiac muscle in the experimental alloxan diabetes. Acta Histochem 1978; 62: 32–43.PubMedCrossRefGoogle Scholar
  20. 20.
    Factor SM, Minase T, Bhan R, Wolinsky H. Hypertensive cardiomyopathy in the rat: Ultrastructural features. Virchows’s Arch Anat 1983; 398: 305–317.Google Scholar
  21. 21.
    Seager MJ, Singal PK, Orchard R, Pierce GN, Dhalla NS. Cardiac cell damage: A primary myocardial disease by streptozotocin-induced chronic diabetes. Br J Exp Pathol 1984; 65: 613–623.PubMedGoogle Scholar
  22. 22.
    Jackson CV, McGrath GM, Tahiliani AG, Vadlamudi RVSV, McNeill JH. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Diabetes 1985;34:876–883.PubMedCrossRefGoogle Scholar
  23. 23.
    Dillmann WH. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes 1980;29:579–582.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • T. Katagiri
    • 1
  • Y. Umezawa
    • 1
  • Y. Suwa
    • 1
  • E. Geshi
    • 1
  • T. Yanagishita
    • 1
  • M. Yaida
    • 1
  1. 1.The Third Department of Internal MedicineShowa University School of MedicineTokyoJapan

Personalised recommendations